Sign Out
Valganciclovir tablets are indicated for the treatment of cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome (AIDS).
Valganciclovir is indicated for the prevention of cytomegalovirus (CMV) disease in kidney, heart, and kidney-pancreas transplant patients at high risk. (Donor CMV seropositive/ Recipient CMV seronegative [(D+/R-)]).
Valganciclovir is not indicated for use in liver transplant patients.
The safety and efficacy of Valganciclovir for the prevention of CMV disease in other solid organ transplant patients such as lung transplant patients have not been established.
Continue with Google